Related Experiment Videos
Actos (pioglitazone): a new treatment for type 2 diabetes
1Diabetes and Lipid Research, Royal United Hospital, Bath BA1 3NG.
Hospital Medicine (London, England : 1998)
|August 2, 2001
Abstract:
Type 2 diabetes is increasingly common and can be difficult to control. By directly targeting insulin resistance, the thiazolidinediones offer a new mode of treatment. Here, the pharmacology, clinical trial evidence, side-effects and current clinical uses of pioglitazone are reviewed.